Maria Elisa Mancuso: Shaping the Future of Hemophilia Care Together!
Maria Elisa Mancuso, Professor of Medicine at Frankfurt University Hospital, Medical Specialist at Humanitas Research Hospital, shared a post on LinkedIn:
“Shaping the future of hemophilia care together!
It was a pleasure to participate in the EHC – European Haemophilia Consortium New Technologies Conference 2026, held in Bucharest on October 31 – November 1.
As Chair of the EHC Medical Advisory Group (MAG), I particularly value the opportunity this meeting offers to bring together clinicians, researchers, and the patient community to discuss the rapidly evolving landscape of bleeding disorders’ treatment.
From new replacement therapies to emerging non-factor therapies and new gene therapy strategies, scientific advances are opening exciting new perspectives.
But innovation also raises important questions about long-term outcomes, safety, access, and, most importantly, what truly matters to people living with bleeding disorders.
The open and constructive discussions throughout the conference once again highlighted the importance of placing patients’ perspectives at the heart of scientific and clinical progress.
A sincere thank you to the EHC team, my fellow speakers, colleagues, and patient representatives for the stimulating exchanges and their continued commitment to improving people care.
The future of treatment for bleeding disorders must be shaped not only by scientific innovation, but also through meaningful collaboration with the people we aim to serve.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 13:58Deniz Aslan: Advancing Pediatric Beta-Thalassemia Screening
-
Nov 14, 2026, 13:56ASPERA-R Study Investigates Anticoagulation Timing Following Breakthrough Ischemic Stroke – International Journal of Stroke
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis
-
Nov 14, 2026, 13:45César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026
-
Nov 14, 2026, 13:41Hussein Abdelwahab: FDA Approves Asundexian as the First Factor XIa Inhibitor for Stroke Prevention
-
Nov 14, 2026, 13:31John Augoustides: Practical Anticoagulation Strategies for Cardiopulmonary Bypass in Patients with HIT
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment